Allogene Therapeutics, Inc. - Common Stock (NQ:ALLO)
2.025
-0.255
(-11.18%)
Streaming Delayed Price
Updated: 12:23 PM EDT, Apr 15, 2026
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
These stocks are making the most noise in today's session. ↗
April 13, 2026
Allogene Therapeutics Stock Hits 52-Week High - Here's Why ↗
April 13, 2026
These stocks are gapping in today's session ↗
April 13, 2026
Which stocks are moving before the opening bell on Monday? ↗
April 13, 2026
Allogene (ALLO) Q4 2025 Earnings Call Transcript ↗
March 12, 2026
The market is filled with gapping stocks in Friday's session. ↗
January 09, 2026
Allogene Arbitration Victory Pressures Cellectis Shares Tuesday ↗
December 16, 2025
Frequently Asked QuestionsIs Allogene Therapeutics, Inc. - Common Stock publicly traded?
Yes, Allogene Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Allogene Therapeutics, Inc. - Common Stock trade on?
Allogene Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Allogene Therapeutics, Inc. - Common Stock?
The ticker symbol for Allogene Therapeutics, Inc. - Common Stock is ALLO on the Nasdaq Stock Market
What is the current price of Allogene Therapeutics, Inc. - Common Stock?
The current price of Allogene Therapeutics, Inc. - Common Stock is 2.025
When was Allogene Therapeutics, Inc. - Common Stock last traded?
The last trade of Allogene Therapeutics, Inc. - Common Stock was at 04/15/26 12:23 PM ET
What is the market capitalization of Allogene Therapeutics, Inc. - Common Stock?
The market capitalization of Allogene Therapeutics, Inc. - Common Stock is 287.92M
How many shares of Allogene Therapeutics, Inc. - Common Stock are outstanding?
Allogene Therapeutics, Inc. - Common Stock has 288M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
| ||||||||||||||||||||||||